Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pLenti CMV/TO RasV12 Puro (w119-1) Citations (12)

Originally described in: shMDC1 plasmids
Unpublished

Articles Citing pLenti CMV/TO RasV12 Puro (w119-1)

Articles
Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells. Zolochevska O, Figueiredo ML. Prostate. 2011 Mar 1;71(4):353-67. doi: 10.1002/pros.21249. Epub 2010 Sep 1. PubMed
Kruppel-like factor 6 interferes with cellular transformation induced by the H-ras oncogene. Trucco LD, Andreoli V, Nunez NG, Maccioni M, Bocco JL. FASEB J. 2014 Dec;28(12):5262-76. doi: 10.1096/fj.14-251884. Epub 2014 Sep 11. PubMed
Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibition. Xu S, Spencer CM, Munger J. J Virol. 2015 Jun;89(12):6406-17. doi: 10.1128/JVI.03671-14. Epub 2015 Apr 8. PubMed
Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection. Xu S, Schafer X, Munger J. J Virol. 2016 Apr 14;90(9):4346-56. doi: 10.1128/JVI.00179-16. Print 2016 May 1. PubMed
Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells. Yoh KE, Regunath K, Guzman A, Lee SM, Pfister NT, Akanni O, Kaufman LJ, Prives C, Prywes R. Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6107-E6116. Epub 2016 Sep 28. PubMed
The Human Cytomegalovirus UL38 protein drives mTOR-independent metabolic flux reprogramming by inhibiting TSC2. Rodriguez-Sanchez I, Schafer XL, Monaghan M, Munger J. PLoS Pathog. 2019 Jan 24;15(1):e1007569. doi: 10.1371/journal.ppat.1007569. eCollection 2019 Jan. PubMed
A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo. Santos L, Colman L, Contreras P, Chini CC, Carlomagno A, Leyva A, Bresque M, Marmisolle I, Quijano C, Duran R, Irigoin F, Prieto-Echague V, Vendelbo MH, Sotelo-Silveira JR, Chini EN, Badano JL, Calliari AJ, Escande C. Sci Rep. 2019 Oct 7;9(1):14381. doi: 10.1038/s41598-019-50789-7. PubMed
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity. He Y, Zhang X, Chang J, Kim HN, Zhang P, Wang Y, Khan S, Liu X, Zhang X, Lv D, Song L, Li W, Thummuri D, Yuan Y, Wiegand JS, Ortiz YT, Budamagunta V, Elisseeff JH, Campisi J, Almeida M, Zheng G, Zhou D. Nat Commun. 2020 Apr 24;11(1):1996. doi: 10.1038/s41467-020-15838-0. PubMed
Disruption of nucleocytoplasmic trafficking as a cellular senescence driver. Park JH, Ryu SJ, Kim BJ, Cho HJ, Park CH, Choi HJC, Jang EJ, Yang EJ, Hwang JA, Woo SH, Lee JH, Park JH, Choi KM, Kwon YY, Lee CK, Park JT, Cho SC, Lee YI, Lee SB, Han JA, Cho KA, Kim MS, Hwang D, Lee YS, Park SC. Exp Mol Med. 2021 Jun;53(6):1092-1108. doi: 10.1038/s12276-021-00643-6. Epub 2021 Jun 29. PubMed
Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro. Raymonda MH, Ciesla JH, Monaghan M, Leach J, Asantewaa G, Smorodintsev-Schiller LA, Lutz MM 4th, Schafer XL, Takimoto T, Dewhurst S, Munger J, Harris IS. Virology. 2022 Jan;566:60-68. doi: 10.1016/j.virol.2021.11.008. Epub 2021 Nov 27. PubMed
Cytomegalovirus-induced inactivation of TSC2 disrupts the coupling of fatty acid biosynthesis to glucose availability resulting in a vulnerability to glucose limitation. Raymonda MH, Rodriguez-Sanchez I, Schafer XL, Smorodintsev-Schiller L, Harris IS, Munger J. bioRxiv. 2023 May 17:2023.05.17.541212. doi: 10.1101/2023.05.17.541212. Preprint. PubMed
Oncogene-Induced Senescence Is a Crucial Antitumor Defense Mechanism of Human Endometrial Stromal Cells. Toropov AL, Deryabin PI, Shatrova AN, Borodkina AV. Int J Mol Sci. 2023 Sep 14;24(18):14089. doi: 10.3390/ijms241814089. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.